SLC39A11 also regulates the expression of calprotectin in myeloid cells, controlling the expression levels of S100A8 and S100A9, the two subunits of calprotectin, an important IBD biomarker for monitoring disease activity (48). This evidence concerns the gene S100A8 and inflammatory bowel disease.